It seems like Genocea has been able to do much better testing in their trials... They have been able to trial different dosages, and different intervals of boosters (with difference dosages).
Will be interesting...!
- Forums
- ASX - By Stock
- hsv2 final results
It seems like Genocea has been able to do much better testing in...
-
- There are more pages in this discussion • 98 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add AVR (ASX) to my watchlist
(20min delay)
|
|||||
Last
$18.31 |
Change
-0.240(1.29%) |
Mkt cap ! $351.9M |
Open | High | Low | Value | Volume |
$18.80 | $19.15 | $18.20 | $159.7K | 8.611K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
1 | 73 | $18.31 |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
$18.33 | 90 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
1 | 73 | 18.310 |
1 | 150 | 18.100 |
1 | 20 | 18.060 |
1 | 100 | 18.050 |
1 | 250 | 18.010 |
Price($) | Vol. | No. |
---|---|---|
18.330 | 90 | 1 |
19.000 | 9589 | 2 |
19.030 | 467 | 1 |
19.290 | 325 | 1 |
19.800 | 264 | 1 |
Last trade - 16.10pm 28/06/2024 (20 minute delay) ? |
Featured News
AVR (ASX) Chart |
The Watchlist
LU7
LITHIUM UNIVERSE LIMITED
Alex Hanly, CEO
Alex Hanly
CEO
SPONSORED BY The Market Online